PGC-1α overexpression results in increased hepatic fatty acid oxidation with reduced triacylglycerol accumulation and secretion.
about
Role of mitochondria in nonalcoholic fatty liver diseaseApolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion.Intrinsic aerobic capacity impacts susceptibility to acute high-fat diet-induced hepatic steatosisTreating NAFLD in OLETF rats with vigorous-intensity interval exercise trainingEnhancing hepatic mitochondrial fatty acid oxidation stimulates eating in food-deprived mice.Mice expressing reduced levels of hepatic glucose-6-phosphatase-α activity do not develop age-related insulin resistance or obesity.Gestational exercise protects adult male offspring from high-fat diet-induced hepatic steatosis.Diabetic and dyslipidaemic morbidly obese exhibit more liver alterations compared with healthy morbidly obeseThe presence of the ovary prevents hepatic mitochondrial oxidative stress in young and aged female mice through glutathione peroxidase 1Fasting-induced liver GADD45β restrains hepatic fatty acid uptake and improves metabolic healthInhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer.Fibroblast growth factor 21 and exercise-induced hepatic mitochondrial adaptations.Reduced hepatic mitochondrial respiration following acute high-fat diet is prevented by PGC-1α overexpression.Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats.Chemokine ligand 2 and paraoxonase-1 in non-alcoholic fatty liver disease: The search for alternative causative factors.α-Linolenic acid supplementation and exercise training reveal independent and additive responses on hepatic lipid accumulation in obese rats."Weighing" the effects of exercise and intrinsic aerobic capacity: are there beneficial effects independent of changes in weight?Impact of various exercise modalities on hepatic mitochondrial function.Selective hepatic insulin resistance in a murine model heterozygous for a mitochondrial trifunctional protein defect.A return to ad libitum feeding following caloric restriction promotes hepatic steatosis in hyperphagic OLETF rats.Aerobic capacity and hepatic mitochondrial lipid oxidation alters susceptibility for chronic high-fat diet-induced hepatic steatosis.TM5441, a plasminogen activator inhibitor-1 inhibitor, protects against high fat diet-induced non-alcoholic fatty liver disease.Fibroblast growth factor 21 increases hepatic oxidative capacity but not physical activity or energy expenditure in hepatic peroxisome proliferator-activated receptor γ coactivator-1α-deficient mice.Aerobic capacity mediates susceptibility for the transition from steatosis to steatohepatitis.PGC-1α may associated with the anti-obesity effect of taurine on rats induced by arcuate nucleus lesion.High-fat diet inhibits PGC-1α suppressive effect on NFκB signaling in hepatocytes.Regulation of Mitochondrial Trifunctional Protein Modulates Nonalcoholic Fatty Liver Disease in Mice.NEFA-induced ROS impaired insulin signalling through the JNK and p38MAPK pathways in non-alcoholic steatohepatitis.The Long Non-coding RNA MEG3/miR-let-7c-5p Axis Regulates Ethanol-Induced Hepatic Steatosis and Apoptosis by Targeting NLRC5.PGC-1α in hepatic UPR during high-fat high-fructose diet and exercise training in mice
P2860
Q27028142-975F5DA4-ECEB-412E-803B-EA147399ABC4Q33858526-11BE0233-F594-4A29-BFCA-DCE6B76FA612Q34062800-23C09724-C756-44EB-8383-DB9C56FAD18EQ34791448-3D4EC482-FC8A-4BD5-BFC6-7542D7F03FE1Q34980719-6DAF36D3-874F-48BA-AA3F-DD1AFCCEB0BDQ35999250-95D9D75E-6D7E-4E19-AB92-54A503BBFDB0Q36405082-4E7553F4-D511-4C7B-8FE8-D4DE464D3619Q36713843-2B795CB0-1675-4F01-8BDC-2E44D235492FQ36776359-E7E8EFBB-09C6-44BB-80A3-D08779839DEFQ36955992-32F1C903-6F4E-443E-B239-9FE635BB6D33Q36967938-5DF7B87C-4D7D-490E-ABAE-90F17A8788C9Q36976053-1F17846F-B77D-4587-8CB6-77A89A0F7934Q37440086-403DB62B-E275-4E8D-BF65-42AC0D6E9153Q37575417-46E0B6E3-8256-4E34-9633-4A00886D8D09Q38381079-101537CA-0F9C-493D-852C-88F75BC34A6EQ38922349-CF9D45A3-1894-40A0-8BC6-580713BFB6D9Q38924578-9524B2DC-F824-4398-BB30-A3914A463601Q39803810-0C575B4A-D671-40D8-BEC2-582E83F8348FQ40906113-394572FD-C32B-4A59-9099-7BEF1F7E4CDDQ41546112-576F176D-2AF1-4E08-8FF9-E566D64D6959Q41630408-0C3D7310-0302-415E-97A5-FC4DBEC05BF5Q45751815-5CCCCFC4-68BC-4E51-800C-47C2CB741870Q47685213-C87D8387-5A96-445C-B920-2FFB37AAE991Q47886086-A9B543F3-F2E7-4656-9A0D-5DA8213EF453Q48549857-29A4CCED-1CB1-40FF-8898-5AF073F287B5Q50625684-F74E7B9B-EA35-4236-A432-A5A9DE6D05C2Q51759255-2A26BB52-8E4A-477B-987B-2C69D55348ECQ52336761-B11444A9-CA99-4FCE-9942-17109AC0B774Q52564669-DF885B7D-D714-46E1-8309-F04101785546Q58783695-6D1CA877-5B42-4974-90A3-8A8442D10383
P2860
PGC-1α overexpression results in increased hepatic fatty acid oxidation with reduced triacylglycerol accumulation and secretion.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
PGC-1α overexpression results ...... ol accumulation and secretion.
@ast
PGC-1α overexpression results ...... ol accumulation and secretion.
@en
type
label
PGC-1α overexpression results ...... ol accumulation and secretion.
@ast
PGC-1α overexpression results ...... ol accumulation and secretion.
@en
prefLabel
PGC-1α overexpression results ...... ol accumulation and secretion.
@ast
PGC-1α overexpression results ...... ol accumulation and secretion.
@en
P2093
P2860
P356
P1476
PGC-1α overexpression results ...... rol accumulation and secretion
@en
P2093
Christopher D Hardin
Frank W Booth
Grace M E Meers
Jamal A Ibdah
Kevin L Fritsche
P2860
P304
P356
10.1152/AJPGI.00169.2012
P577
2012-08-16T00:00:00Z